Overview

Europe Bioreactors Market is poised to value over USD 1.5 billion by 2027 end at a CAGR of over 7% during the forecast period 2020 to 2027

FutureWise Market Research has instantiated a report that provides an intricate analysis of Europe Bioreactors Market  trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Europe Bioreactors Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

Major players included in the Europe Bioreactors Market:
• Sartorius AG
• Cellexus
• bbi-biotech GmbH
• GEA Group
• Applikon Biotechnology BV
• MERCK KGaA
• CerCell ApS
• Eppendorf AG
• Cytiva
• Pierre Guerin Sas
• Solaris Biotechnology Srl
• Thermo Fisher Scientific
• Solida Biotech GmbH
(Note: The list of the major players will be updated with the latest market scenario and trends)

Europe Bioreactors Market Segmentation:
By Cell
• Mammalian Cells
• Bacterial Cells
• Yeast Cells
• Others

By Molecule
• Monoclonal Antibodies
• Vaccines
• Recombinant Proteins
• Stem Cells
• Gene Therapy
• Others

By Technology
• Wave-Induced Motion SUB
• Stirred SUB
• Single-Use Bubble Column
• Other Technologies

By End User
• Biopharma Manufacturers
• Contract Manufacturing Organisations (CMOs)

By Region
• Germany
• U.K
• France
• Italy
• Spain
• Russia
• Poland
• Rest of Europe

Competitive Landscape:
• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants

FutureWise Key Takeaways:
• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth

Objectives of the Study:
• To provide with an exhaustive analysis on the Europe Bioreactors Market By Cell, By Molecule, By Technology, By End User and By Region.
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— Germany, U.K, France, Italy, Spain, Russia, Poland, Rest of Europe
• To record and evaluate competitive landscape mapping- Product launches, technological advancements, mergers and expansions

Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization Mobility Care offered are free of charge with purchase of any license of the report
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents

1. Market Introduction
  1.1 Objectives of the Study
  1.2 Market Definition
  1.3 Market Scope
      1.3.1 Years Considered for the Study
      1.3.2 Market Covered
  1.4 Currency
  1.5 Limitations
  1.6 Stakeholders

2. Research Methodology
   2.1 Research Data
       2.1.1 Secondary Data
             2.1.1.1 Key Data from Secondary Sources
       2.1.2 Primary Data
             2.1.2.1 Key Data from Primary Sources
   2.2 Market Size Estimation
   2.3 Market Breakdown and Data Triangulation
   2.4 Assumptions for the Study  

3. Executive Summary
  3.1 Market Outlook
  3.2 Segment Outlook
  3.3 Competitive Insights

4. Europe Bioreactors Market Variables, Trends & Scope
  4.1. Market Lineage Outlook
  4.2. Penetration and Growth Prospect Mapping
  4.3. Industry Value Chain Analysis
  4.4. Cost Analysis Breakdown
  4.5. Technology Overview
  4.6. Regulatory Framework
       4.6.1. Reimbursement Framework
       4.6.2. Standards and Compliances

5. Market Overview
  5.1. Market Dynamics
       5.1.1. Market Driver Analysis
              5.1.1.1. Increasing focus of Europe Bioreactors Market Companies on Brand Protection
              5.1.1.2. Untapped Opportunities in Emerging Regions
       5.1.2. Market Restraint Analysis
              5.1.2.1. High Cost Associated with Implementation of Predictive Analysis
       5.1.3. Industry Challenges
              5.1.3.1. Presence of Ambiguous Regulatory Framework

6. Europe Bioreactors Market Analysis Tools
  6.1. Industry Analysis - Porter’s
       6.1.1. Supplier Power
       6.1.2. Buyer Power
       6.1.3. Substitution Threat
       6.1.4. Threat from New Entrants
       6.1.5. Competitive Rivalry
  6.2. Pestel Analysis
       6.2.1. Political Landscape
       6.2.2. Environmental Landscape
       6.2.3. Social Landscape
       6.2.4. Technology Landscape
       6.2.5. Legal Landscape
  6.3. Major Deals And Strategic Alliances Analysis
       6.3.1. Joint Ventures
       6.3.2. Mergers and Acquisitions
       6.3.3. Licensing and Partnership
       6.3.4. Technology Collaborations
       6.3.5. Strategic Divestments
  6.4. Market Entry Strategies
  6.5. Case Studies

7. Europe Bioreactors Market, By Cell Historical Analysis and Forecast 2020-2027 (USD Million)
  7.1. Mammalian Cells
  7.2. Bacterial Cells
  7.3. Yeast Cells
  7.4. Others

8. Europe Bioreactors Market, By Molecule Historical Analysis and Forecast 2020-2027 (USD Million)
  8.1. Monoclonal Antibodies
  8.2. Vaccines
  8.3. Recombinant Proteins
  8.4. Stem Cells
  8.5. Gene Therapy
  8.6. Others

9. Europe Bioreactors Market, By Technology Historical Analysis and Forecast 2020-2027 (USD Million)
  9.1. Wave-Induced Motion SUB
  9.2. Stirred SUB
  9.3. Single-Use Bubble Column
  9.4. Other Technologies

10. Europe Bioreactors Market, By End User Historical Analysis and Forecast 2020-2027 (USD Million)
   10.1. Biopharma Manufacturers
   10.2. Contract Manufacturing Organisations (CMOs)

11. Europe Bioreactors Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
   11.1. Introduction
   11.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
         11.2.1. Germany
         11.2.2. U.K        
         11.2.3. France
         11.2.4. Italy
         11.2.5. Spain
         11.2.6. Russia
         11.2.7. Poland
         11.2.8. Rest of Europe
   11.3. Market Size (USD Million) Forecast for Europe 2020-2027

12. Market Share Analysis and Competitive Landscape  
   12.1. Europe Landscape - Key Players, Revenue and Presence
   12.2. Europe Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
   12.3. Europe Emerging Companies
   12.4. Europe - Market Share Analysis and Key Regional Players
   12.5. Europe Key Player - Growth Matrix

13. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
   13.1. Sartorius AG
         13.1.1. Company Overview
         13.1.2. Product Portfolio
         13.1.3. SWOT Analysis
         13.1.4. Financial Overview
         13.1.5. Strategic Overview
   13.2. Cellexus
         13.2.1. Company Overview
         13.2.2. Product Portfolio
         13.2.3. SWOT Analysis
         13.2.4. Financial Overview
         13.2.5. Strategic Overview
   13.3. bbi-biotech GmbH
         13.3.1. Company Overview
         13.3.2. Product Portfolio
         13.3.3. SWOT Analysis
         13.3.4. Financial Overview
         13.3.5. Strategic Overview
   13.4. GEA Group
         13.4.1. Company Overview
         13.4.2. Product Portfolio
         13.4.3. SWOT Analysis
         13.4.4. Financial Overview
         13.4.5. Strategic Overview
   13.5. Applikon Biotechnology BV
         13.5.1. Company Overview
         13.5.2. Product Portfolio
         13.5.3. SWOT Analysis
         13.5.4. Financial Overview
         13.5.5. Strategic Overview          
   13.6. MERCK KGaA
         13.6.1. Company Overview
         13.6.2. Product Portfolio
         13.6.3. SWOT Analysis
         13.6.4. Financial Overview
         13.6.5. Strategic Overview      
   13.7. CerCell ApS
         13.7.1. Company Overview
         13.7.2. Product Portfolio
         13.7.3. SWOT Analysis
         13.7.4. Financial Overview
         13.7.5. Strategic Overview
   13.8. Eppendorf AG
         13.8.1. Company Overview
         13.8.2. Product Portfolio
         13.8.3. SWOT Analysis
         13.8.4. Financial Overview
         13.8.5. Strategic Overview
   13.9. Cytiva
         13.9.1. Company Overview
         13.9.2. Product Portfolio
         13.9.3. SWOT Analysis
         13.9.4. Financial Overview
         13.9.5. Strategic Overview
   13.10.Pierre Guerin Sas
         13.10.1.Company Overview
         13.10.2.Product Portfolio
         13.10.3.SWOT Analysis
         13.10.4.Financial Overview
         13.10.5.Strategic Overview
   13.11.Solaris Biotechnology Srl
         13.11.1.Company Overview
         13.11.2.Product Portfolio
         13.11.3.SWOT Analysis
         13.11.4.Financial Overview
         13.11.5.Strategic Overview
   13.12.Thermo Fisher Scientific
         13.12.1.Company Overview
         13.12.2.Product Portfolio
         13.12.3.SWOT Analysis
         13.12.4.Financial Overview
         13.12.5.Strategic Overview
   13.13.Solida Biotech GmbH
         13.13.1.Company Overview
         13.13.2.Product Portfolio
         13.13.3.SWOT Analysis
         13.13.4.Financial Overview
         13.13.5.Strategic Overview

14. Pre and Post COVID-19 Impact
   14.1. Positive influence on the healthcare industry
   14.2. The financial disruption of the manufacturing sector
   14.3. Impact of COVID-19 on emerging companies
   14.4. Significant mandates in the healthcare regulations initiated by administrations
   14.5. The overall economic slowdown of the developing and developed nations

15. FutureWise SME Key Takeaway Points for Client

Tables

Figures